Results 131 to 140 of about 786 (145)

[Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir]. [PDF]

Med Clin (Barc), 2020
Brandariz-Nuñez D, Correas-Sanahuja M, Guarc E, Picón R, García B, Gil R.   +5 more
europepmc   +1 more source

[Design of a Tool for Patient Classification Based on Pharmacotherapeutic Attitudes]. [PDF]

Farm Comunitarios
Reyes Estévez D, Charola Ramos L, Horas Barrera C, Mencias Hurtado AB, Arranz Durán J, Martínez Carretero E.   +5 more
europepmc   +1 more source

[Effects of statins on bone mineral density of postmenopausal women from Córdoba, Argentina] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Astesana PJ, Alba PB, Gobbi CA, Albiero EH, Yorio MA.   +4 more
europepmc   +1 more source

Patisiran Treatment in the Brazilian Subpopulation of the Phase 3 APOLLO-B Study in Transthyretin Amyloidosis with Cardiomyopathy: Post Hoc Analysis. [PDF]

Arq Bras Cardiol
Mesquita CT, Schwartzmann P, Correia EB, Simões MV, Biolo A, Duque DR, Jay PY, Fernandes F.   +7 more
europepmc   +1 more source

Pharmacogenomics and Cardiovascular Disease: Where are We and Where do We go from Here? [PDF]

Arq Bras Cardiol, 2020
Stein R, Beuren T, Cela LR, Ferrari F.
europepmc   +1 more source

An FT-Raman, FT-IR, and Quantum Chemical Investigation of Stanozolol and Oxandrolone. [PDF]

Biosensors (Basel), 2017
Lemma T, de Barros Souza F, Tellez Soto CA, Martin AA.   +3 more
europepmc   +1 more source

La gestione value-based del paziente adulto con Ipertensione Arteriosa Polmonare: Health Technology Assessment di sotatercept. [PDF]

J Prev Med Hyg
Calabrò GE, DE Belvis AG, Bert F, Lo Moro G, Scaioli G, D'Ambrosio F, DE Donno R, Scarfagna C, Ricciardi R, Vizza D, D'Alto M, Ghio S, Limongelli G, Poscia R, Sciattella P, Paoletti M, Marcellusi A, Ricciardi W.   +17 more
europepmc   +1 more source

Prevalence of polypharmacy use and association with mortality: a cohort study of elderly people in Southern Brazil, 2014-2017. [PDF]

Epidemiol Serv Saude
Müller CH, Bertoldi AD, Bielemann RM, Machado KP, Tomasi E, Gonzalez MC, Silveira MPT.   +6 more
europepmc   +1 more source

Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective. [PDF]

J Bras Nefrol
Rico-Fontalvo J, Reina M, Soler MJ, Unigarro-Palacios M, Castañeda-González JP, Quintero JJ, Raad-Sarabia M, Moraes TP, Daza-Arnedo R.   +8 more
europepmc   +1 more source